Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2007 3
2009 3
2010 1
2011 2
2012 6
2013 7
2014 10
2015 14
2016 22
2017 21
2018 18
2019 24
2020 34
2021 54
2022 46
2023 27
2024 27
2025 48
2026 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

341 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for E. sadoughi
Search for E. Sadooghi instead (2 results)
The Effects of Vitamin Therapy on ASD and ADHD: A Narrative Review.
Poudineh M, Parvin S, Omidali M, Nikzad F, Mohammadyari F, Sadeghi Poor Ranjbar F, Rasouli F, Nanbakhsh S, Olangian-Tehrani S. Poudineh M, et al. CNS Neurol Disord Drug Targets. 2023;22(5):711-735. doi: 10.2174/1871527321666220517205813. CNS Neurol Disord Drug Targets. 2023. PMID: 35585808 Review.
In this review, we aim to evaluate the effects of vitamins and other dietary supplements (e.g., melatonin, zinc supplements, magnesium supplements) on ASD and ADHD....
In this review, we aim to evaluate the effects of vitamins and other dietary supplements (e.g., melatonin, zinc supplements, magnesiu …
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Disease and Injury and Risk Factor Collaborators. GBD 2023 Disease and Injury and Risk Factor Collaborators. Lancet. 2025 Oct 18;406(10513):1873-1922. doi: 10.1016/S0140-6736(25)01637-X. Epub 2025 Oct 12. Lancet. 2025. PMID: 41092926 Free PMC article.
The experiences of preparation and engagement of educators in teaching e-portfolio.
Keshmiri F, Mehrparvar AH. Keshmiri F, et al. BMC Med Educ. 2023 Sep 18;23(1):674. doi: 10.1186/s12909-023-04642-1. BMC Med Educ. 2023. PMID: 37723517 Free PMC article.
The current study was aimed at describing teaching e-portfolio components at Shahid Sadoughi University of Medical Sciences. As well, we examined the performance and experience of educators in engaging in the teaching e-portfolio. MATERIALS AND METHODS: This …
The current study was aimed at describing teaching e-portfolio components at Shahid Sadoughi University of Medical Sciences. A …
Mortality, perioperative complications and surgical timelines in hip fracture patients: Comparison of the Spanish with the non-Spanish Cohort of the HIP ATTACK-1 trial.
Guerra-Farfan E, Borges FK, Bhandari M, Garcia-Sanchez Y, Nuñez JH, Mestre-Torres J, Tomas-Hernandez J, Teixidor-Serra J, Balaguer-Castro M, Castillon P, Dealbert A, De Caso Rodriguez J, Aguado HJ, Guerado E, Popova E, Tonelli AC, Balasubramanian K, Vincent J, Harvey V, Kocaqi E, Slobogean G, Devereaux PJ; Hip Attack-1 Investigators. Guerra-Farfan E, et al. Injury. 2024 Nov;55(11):111827. doi: 10.1016/j.injury.2024.111827. Epub 2024 Aug 20. Injury. 2024. PMID: 39217648 Clinical Trial.
The effect of vitamin E supplementation on selected inflammatory biomarkers in adults: a systematic review and meta-analysis of randomized clinical trials.
Asbaghi O, Sadeghian M, Nazarian B, Sarreshtedari M, Mozaffari-Khosravi H, Maleki V, Alizadeh M, Shokri A, Sadeghi O. Asbaghi O, et al. Sci Rep. 2020 Oct 14;10(1):17234. doi: 10.1038/s41598-020-73741-6. Sci Rep. 2020. PMID: 33057114 Free PMC article.
Moreover, we found a significant reducing effect of vitamin E supplementation on tumor necrosis factor-alpha (TNF-alpha) concentrations at high dosages of vitamin E; such that based on dose-response analysis, serum TNF-alpha concentrations were reduced significantly …
Moreover, we found a significant reducing effect of vitamin E supplementation on tumor necrosis factor-alpha (TNF-alpha) concentratio …
Autoimmune progesterone anaphylaxis.
Bemanian MH, Gharagozlou M, Farashahi MH, Nabavi M, Shirkhoda Z. Bemanian MH, et al. Iran J Allergy Asthma Immunol. 2007 Jun;6(2):97-9. Iran J Allergy Asthma Immunol. 2007. PMID: 17563411 Free article.
Women with the disorder commonly present with dermatologic lesions in the luteal phase of the menstrual cycle, if there are any other organ involvement in addition to skin (e.g. lung, GI) the reaction should be called as autoimmune progesterone anaphylaxis. ...
Women with the disorder commonly present with dermatologic lesions in the luteal phase of the menstrual cycle, if there are any other organ …
A review of cardioprotective effect of ginsenosides in chemotherapy-induced cardiotoxicity.
Zare-Zardini H, Hedayati-Goudarzi MT, Alizadeh A, Sadeghian-Nodoushan F, Soltaninejad H. Zare-Zardini H, et al. Biomed Eng Online. 2024 Dec 21;23(1):128. doi: 10.1186/s12938-024-01322-z. Biomed Eng Online. 2024. PMID: 39709452 Free PMC article. Review.
Strategies to mitigate chemotherapy-induced cardiotoxicity may include the use of cardioprotective agents (e.g., dexrazoxane), dose adjustments, alternative treatment regimens, and the implementation of preventive measures, such as lifestyle modifications and the managemen …
Strategies to mitigate chemotherapy-induced cardiotoxicity may include the use of cardioprotective agents (e.g., dexrazoxane), dose a …
Efficacy and safety of a proposed omalizumab biosimilar compared to the reference product in the management of uncontrolled moderate-to-severe allergic asthma: a multicenter, phase III, randomized, double-blind, equivalency clinical trial.
Ghanei M, Ghalebaghi B, Sami R, Torabizadeh M, Mirsadraee M, Amra B, Tavakol M, Raji H, Fallahpour M, Kiani A, Abedini A, Jabbari Azad F, Mahdaviani SA, Attaran D, Samet M, Tavana S, Haddadzadeh Shoushtari M, Nazari J, AghaeiMeybodi F, Fazlollahi MR, Ghasemi R, Sabzvari A, Kafi H, Idani E. Ghanei M, et al. Front Immunol. 2024 Jul 29;15:1425906. doi: 10.3389/fimmu.2024.1425906. eCollection 2024. Front Immunol. 2024. PMID: 39136011 Free PMC article. Clinical Trial.
A significant portion of moderate-to-severe allergic asthma patients need omalizumab, an anti-immunoglobulin-E monoclonal antibody, as an add-on therapy. In this phase III clinical trial P043 (Zerafil( ), CinnaGen, Iran) efficacy, safety, and immunogenicity were compared w …
A significant portion of moderate-to-severe allergic asthma patients need omalizumab, an anti-immunoglobulin-E monoclonal antibody, a …
341 results